Shopping Cart 0
Cart Subtotal
USD 0

MediPoint: Pancreatic and Biliary Stents-Asia-Pacific Analysis and Market Forecasts

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 5000

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 10000

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 15000

Details

MediPoint: Pancreatic and Biliary Stents-Asia-Pacific Analysis and Market Forecasts

Summary

The pancreatic and biliary stents market is driven by two procedures: endoscopic retrograde cholangiopancreatography and percutaneous transhepatic cholangiography. There are four primary pancreatic and biliary stents; the covered metal stents, the partially covered metal stents, the non-covered metal stents, and plastic stents. The market will continue to grow as cancer prevalence increases and patients become more familiar with stenting as a treatment option. This report examines the pancreatic and biliary stents market in seven major Asia-Pacific (APAC) markets: Australia, China, India, Japan, New Zealand, South Korea, and Taiwan

This report provides insight into the adoption trends, market dynamics, competitive landscape, marketed products, current players, as well as market outlooks in the APAC market.

Key Questions Answered

What is the current and future pancreatic and biliary stents market outlook in APAC? What trends are affecting the APAC market?

What is the competitive landscape and market share of major players in the pancreatic and biliary stents space in APAC?

What are the key, high growth markets that pancreatic and biliary stents manufacturers should expand into? Which market segments are growing the fastest?

What is physician perception and market outlook of pancreatic and biliary stents?

Scope

Data tables covering sales volume, average selling price, market values, and company share analysis

Competitive Assessment of major players in the market and currently marketed pancreatic and biliary stents

In-depth Analysis of the pancreatic and biliary stents market revenue by segment and market outlooks by region and country from 2014 to 2023.

Other key topics covered include market characterization, market dynamics, and market trends

Reasons to buy

The report will enable you to-

Develop and design your in-licensing and out-licensing strategies through a review of marketed products and technologies.

Develop business strategies by understanding the trends shaping and driving pancreatic and biliary stents market.

Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the pancreatic and biliary stents market in the future.

Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.

Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.

Track device sales in the global and country-specific pancreatic and biliary stents market from 2014-2023.

Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

READ MORE

Table Of Content

Scope

Table of Contents

1 About the Authors 2

1.1 Analysts 2

1.1.1 Global Head of Medical Devices 2

2 Table of Contents 3

2.1 List of Tables 5

2.2 List of Figures 5

3 Executive Summary 6

3.1 Overview 6

3.2 Market Dynamics 8

3.3 Key Players 8

3.4 Future Outlook 8

4 Introduction 9

4.1 Catalyst 9

4.2 Related Reports 9

5 Market Outlook 10

5.1 Procedure Trends 10

5.2 Pricing Trends 12

5.3 Revenue Trends 13

5.4 Company Share Analysis 15

6 Market Insights 16

6.1 APAC 16

6.1.1 Australia and New Zealand 16

6.1.2 China and Taiwan 16

6.1.3 India 16

6.1.4 Japan 16

6.1.5 South Korea 17

7 Competitive Assessment 18

7.1 Boston Scientific 18

7.1.1 Overview 18

7.1.2 Portfolio Assessment 18

7.1.3 Competitive Positioning 18

7.2 Cook Medical 19

7.2.1 Overview 19

7.2.2 Portfolio Assessment 19

7.2.3 Competitive Positioning 19

7.3 ELLA-CS 20

7.3.1 Overview 20

7.3.2 Portfolio Assessment 20

7.4 Taewoong Medical 20

7.4.1 Overview 20

7.4.2 Portfolio Assessment 20

7.4.3 Competitive Positioning 21

7.5 Others 21

8 Appendix 22

8.1 Bibliography 22

8.2 Abbreviations 23

8.3 Methodology 24

8.3.1 Overview 24

8.3.2 Coverage 24

8.3.3 Secondary Research 24

8.3.4 Forecasting Methodology 25

8.3.5 Primary Research Summary 26

8.4 About MediPoint 27

8.5 About GlobalData 27

8.6 Contact Us 27

8.7 Disclaimer 28


List Of Figure

List of Figures

Figure 1: Pancreatic and Biliary Stents Sales for APAC by Country, 2016 and 2023 7


List Of Table

List of Tables

Table 1: Key Metrics in the APAC Pancreatic and Biliary Stents Market 6

Table 2: APAC Pancreatic and Biliary Stenting Procedure Volume Forecast, 2014-2023 10

Table 3: APAC Pancreatic and Biliary Stents Average Selling Price Forecast, 2014-2023 12

Table 4: APAC Pancreatic and Biliary Stents Sales Forecast ($M), 2014-2023 13

Table 5: APAC Company Share Analysis, 2016 15

Table 6: Product Portfolio-Boston Scientific 18

Table 7: Product Portfolio-Cook Medical 19

Table 8: Product Portfolio-ELLA-CS 20

Table 9: Product Portfolio-Taewoong Medical 20

Table 10 Other Players Assessment 21

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies


Companies

Boston Scientific, Cook Medical, ELLA-CS, Taewoong Medical

Company Profile

Company Profile Title

MediPoint: Pancreatic and Biliary Stents-Asia-Pacific Analysis and Market Forecasts

Summary

The pancreatic and biliary stents market is driven by two procedures: endoscopic retrograde cholangiopancreatography and percutaneous transhepatic cholangiography. There are four primary pancreatic and biliary stents; the covered metal stents, the partially covered metal stents, the non-covered metal stents, and plastic stents. The market will continue to grow as cancer prevalence increases and patients become more familiar with stenting as a treatment option. This report examines the pancreatic and biliary stents market in seven major Asia-Pacific (APAC) markets: Australia, China, India, Japan, New Zealand, South Korea, and Taiwan

This report provides insight into the adoption trends, market dynamics, competitive landscape, marketed products, current players, as well as market outlooks in the APAC market.

Key Questions Answered

What is the current and future pancreatic and biliary stents market outlook in APAC? What trends are affecting the APAC market?

What is the competitive landscape and market share of major players in the pancreatic and biliary stents space in APAC?

What are the key, high growth markets that pancreatic and biliary stents manufacturers should expand into? Which market segments are growing the fastest?

What is physician perception and market outlook of pancreatic and biliary stents?

Scope

Data tables covering sales volume, average selling price, market values, and company share analysis

Competitive Assessment of major players in the market and currently marketed pancreatic and biliary stents

In-depth Analysis of the pancreatic and biliary stents market revenue by segment and market outlooks by region and country from 2014 to 2023.

Other key topics covered include market characterization, market dynamics, and market trends

Reasons to buy

The report will enable you to-

Develop and design your in-licensing and out-licensing strategies through a review of marketed products and technologies.

Develop business strategies by understanding the trends shaping and driving pancreatic and biliary stents market.

Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the pancreatic and biliary stents market in the future.

Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.

Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.

Track device sales in the global and country-specific pancreatic and biliary stents market from 2014-2023.

Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

READ MORE

Scope

Table of Contents

1 About the Authors 2

1.1 Analysts 2

1.1.1 Global Head of Medical Devices 2

2 Table of Contents 3

2.1 List of Tables 5

2.2 List of Figures 5

3 Executive Summary 6

3.1 Overview 6

3.2 Market Dynamics 8

3.3 Key Players 8

3.4 Future Outlook 8

4 Introduction 9

4.1 Catalyst 9

4.2 Related Reports 9

5 Market Outlook 10

5.1 Procedure Trends 10

5.2 Pricing Trends 12

5.3 Revenue Trends 13

5.4 Company Share Analysis 15

6 Market Insights 16

6.1 APAC 16

6.1.1 Australia and New Zealand 16

6.1.2 China and Taiwan 16

6.1.3 India 16

6.1.4 Japan 16

6.1.5 South Korea 17

7 Competitive Assessment 18

7.1 Boston Scientific 18

7.1.1 Overview 18

7.1.2 Portfolio Assessment 18

7.1.3 Competitive Positioning 18

7.2 Cook Medical 19

7.2.1 Overview 19

7.2.2 Portfolio Assessment 19

7.2.3 Competitive Positioning 19

7.3 ELLA-CS 20

7.3.1 Overview 20

7.3.2 Portfolio Assessment 20

7.4 Taewoong Medical 20

7.4.1 Overview 20

7.4.2 Portfolio Assessment 20

7.4.3 Competitive Positioning 21

7.5 Others 21

8 Appendix 22

8.1 Bibliography 22

8.2 Abbreviations 23

8.3 Methodology 24

8.3.1 Overview 24

8.3.2 Coverage 24

8.3.3 Secondary Research 24

8.3.4 Forecasting Methodology 25

8.3.5 Primary Research Summary 26

8.4 About MediPoint 27

8.5 About GlobalData 27

8.6 Contact Us 27

8.7 Disclaimer 28


List Of Figure

List of Figures

Figure 1: Pancreatic and Biliary Stents Sales for APAC by Country, 2016 and 2023 7


List Of Table

List of Tables

Table 1: Key Metrics in the APAC Pancreatic and Biliary Stents Market 6

Table 2: APAC Pancreatic and Biliary Stenting Procedure Volume Forecast, 2014-2023 10

Table 3: APAC Pancreatic and Biliary Stents Average Selling Price Forecast, 2014-2023 12

Table 4: APAC Pancreatic and Biliary Stents Sales Forecast ($M), 2014-2023 13

Table 5: APAC Company Share Analysis, 2016 15

Table 6: Product Portfolio-Boston Scientific 18

Table 7: Product Portfolio-Cook Medical 19

Table 8: Product Portfolio-ELLA-CS 20

Table 9: Product Portfolio-Taewoong Medical 20

Table 10 Other Players Assessment 21

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS


Companies

Boston Scientific, Cook Medical, ELLA-CS, Taewoong Medical